文献速递主动脉疾病

开放动脉瘤囊缝合术治疗腹主动脉瘤腔内修复术后囊扩张的演变

Evolution of open aneurysmorrhaphy for management of sac expansion after endovascular repair of abdominal aortic aneurysms.
PubMed 文献 · J Vasc Surg · 2022-10-26

本研究回顾性分析了2015年1月至2021年6月在本中心因标准EVAR术后非破裂性囊扩张而接受开放动脉瘤囊缝合术(OA)的28例患者,评估其围手术期及中期结局。OA包括不游离近远端瘤颈的囊显露、囊切开及反流血血管结扎、保留原有支架移植物并紧密缝合囊壁。结果显示30天死亡率为0%,中位随访36个月无动脉瘤相关死亡,2017年后改进技术(更积极游离囊壁并彻底清除附壁血栓)者囊再生长率更低。

要点

  • OA术后30天死亡率为0%,中位随访36个月无动脉瘤相关死亡。
  • 2017年后改进技术组囊再生长率中位0 mm/月,低于早期组的0.36 mm/月(P=0.0075)。
  • 改进技术组免于再干预率12个月和36个月均为94.7%,早期组分别为71.4%和53.6%(log-rank P=0.070)。

核心结论

  • OA用于治疗EVAR术后囊扩张可行,中期结局可接受。
  • 作者认为,更积极的囊壁游离和紧密缝合可能对改善OA后中期结局至关重要。

研究设计与样本

  • 回顾性综述2015年1月至2021年6月在本机构因标准EVAR术后非破裂性囊扩张接受OA的所有患者。
  • 共28例患者,平均年龄76.9±6.7岁。
  • OA技术包括不游离近远端瘤颈的囊显露、囊切开及反流血血管结扎、保留原有支架移植物、紧密缝合囊壁周围。
  • 2017年后技术改进,增加更积极的囊壁游离并彻底清除附壁血栓。
  • 主要终点为30天死亡率和动脉瘤相关死亡,次要终点为术后并发症、总生存率、免于再干预率和囊再生长率。

主要发现

  • OA时中位囊直径79 mm(IQR 76-92 mm),从初次EVAR至OA的中位时间82个月(IQR 72-104个月)。
  • 术前CTA确认20例存在II型内漏,其中1例合并Ia型内漏;1例发现IIIb型内漏。
  • 6例患者同期行血管腔内操作以处理I或III型内漏或加强近远端封闭。
  • 术后并发症2例,分别为腹部淋巴漏和股总动脉止血失败需手术修复各1例。
  • 30天死亡率为0%;中位随访36个月(IQR 14-51个月)期间,12个月和36个月总生存率分别为92.7%和86.9%,无动脉瘤相关死亡。

关键数值与推荐

  • 晚期(2017-2021)治疗组OA后即刻中位囊直径小于早期(2015-2016)治疗组(早期组:中位50 mm,IQR 39-57 mm vs 晚期组:中位41 mm,IQR 32-47 mm;P=0.083)。
  • 晚期组囊再生长率更低(早期组:中位0.36 mm/月,IQR 0.23-0.83 mm/月 vs 晚期组:中位0 mm/月,IQR 0-0.11 mm/月;P=0.0075)。
  • 晚期组免于再干预率更高(晚期组:12个月和36个月均为94.7%;早期组:12个月71.4%,36个月53.6%;log-rank P=0.070)。

临床怎么用

  • 作者认为,OA用于管理EVAR术后囊扩张可行,中期结局可接受。
  • 作者认为,更积极的囊壁游离和紧密缝合可能对改善OA后中期结局至关重要。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We evaluated the perioperative and mid-term clinical outcomes of open aneurysmorrhaphy (OA) for the treatment of sac expansion after endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms. METHODS: OA involves sac exposure without dissection of the proximal or distal neck, sacotomy and ligation of back-bleeding vessels, preservation of the prior stent graft, and tight closure of the sac around the stent graft. We performed a retrospective review of all patients who had undergone OA for nonruptured sac expansion after standard EVAR at our institution between January 2015 and June 2021. The primary end points were 30-day mortality and aneurysm-related death. The secondary end points were postoperative complications, overall survival, freedom from reintervention, and sac regrowth rate. RESULTS: A total of 28 patients had undergone OA. Their mean age was 76.9 ± 6.7 years. The median sac diameter at OA was 79 mm (interquartile range [IQR], 76-92 mm). The median duration from the index EVAR to OA was 82 months (IQR, 72-104 months). Preoperative computed tomography angiography confirmed a type II endoleak (EL) in 20 patients, 1 of whom had had a coexisting type Ia EL; a type IIIb EL was identified in 1 patient. Concomitant endovascular procedures had been performed in six patients to treat a type I or III EL or reinforce the proximal and distal seals. The OA technique has been modified since 2017, with the addition of more aggressive dissection of the sac and complete removal of the mural thrombus to further decrease the sac diameter. Postoperative complications occurred in two patients and included abdominal lymphorrhea and failed hemostasis of the common femoral artery requiring surgical repair in one patient each. The 30-day mortality was 0%. During the median follow-up of 36 months (IQR, 14-51 months), the overall survival was 92.7% and 86.9% at 12 and 36 months, respectively, without any aneurysm-related death. In the late (2017-2021) treatment group, the median sac diameter immediately after OA was smaller than that in the early (2015-2016) treatment group (early group: median, 50 mm; IQR, 39-57 mm; vs later group: median, 41 mm; IQR, 32-47 mm; P = .083). Furthermore, in the late group, the sac regrowth rate was lower (early group: median, 0.36 mm/mo; IQR, 0.23-0.83 mm/mo; vs late group: median, 0 mm/mo; IQR, 0-0.11 mm/mo; P = .0075) and the freedom from reintervention rate was higher (late group: 94.7% at both 12 and 36 months, respectively; early group: 71.4% and 53.6% at 12 and 36 months, respectively; log-rank P = .070). CONCLUSIONS: Our results have shown that OA for the management of post-EVAR sac expansion is feasible with acceptable mid-term outcomes. Aggressive dissection and tight plication of the sac might be imperative for better mid-term outcomes after OA.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Ozawa H, Ohki T, Shukuzawa K, et al. Evolution of open aneurysmorrhaphy for management of sac expansion after endovascular repair of abdominal aortic aneurysms. J Vasc Surg. 2022. PMID: 36306936. doi:10.1016/j.jvs.2022.10.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。